Merged with: Antibody, immunoconjugates, and radiopharmaceuticals, to form: Cancer biotherapy & radiopharceuticals
Holdings: Vol. 8, no. 1 (spring 1993)-v. 10, no. 4 (winter 1995)
Related titles: Continues: Selected cancer therapeutics ; Continued by: Cancer biotherapy & radiopharceuticals
For USC users only. Requires USC network connection.
